Meningococcus Vaccine Study
Participants needed: Age: 28-40
Are you protected against 4 types of Meningococcal Disease?
- Meningococcus is a family of germs (bacteria) that can cause meningitis, which is an infection of the surface of the brain.
- Meningitis is rare, but it can be life-threatening or lead to permanent disability.
- Common groups of meningococcus that can cause disease are A, C, W and
Am I eligible to participate?
- Men and women, ages 28 to 40 years, in good health, who have not previously received a meningococcal vaccine.
What is the purpose of the study?
- The meningococcus vaccine that is currently used, comes in two vials: one is a liquid, and the other vial has a separate part that comes as a solid pellet. The doctor or nurse has to mix the two vials before giving it to you. This takes time during the visits and also requires more storage space
- GSK has developed a new version of the vaccine that is one vial containing all four parts as a liquid. It takes less time to prepare and less space to store it.
- This study will test to see if the new liquid injection vaccine is as safe and works as well as the current vaccine.
- Two visits over a six-month period. There are two blood draws, one vaccination, and three follow-up phone calls.
- Participants will receive either a licensed or investigational Men ACWY Vaccine.
You will receive:
- Reimbursement for your out of pocket expenses related to the study such as travel and parking.
Contact Jill Mutch
Phone (902) 470-3860